<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 16:26:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  144        Vericel Corp                           Filed by: Flynn Sean C.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Flynn+Sean+C./26666461.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666461.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Flynn+Sean+C./26666461.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00644714</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Form  144        Vericel Corp                           Filed by: Flynn Sean C.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Flynn+Sean+C./26666461.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666461.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Flynn+Sean+C./26666461.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00644714</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Form  144        Vericel Corp                           Filed by: Halpin Michael</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Halpin+Michael/26666119.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666119.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Halpin+Michael/26666119.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00644714</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Form  144        Vericel Corp                           Filed by: Halpin Michael</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Halpin+Michael/26666119.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666119.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Vericel+Corp+++++++++++++++++++++++++++Filed+by%3A+Halpin+Michael/26666119.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00644714</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
 </channel>
</rss>
